Navigation Links
Plato BioPharma, Inc Appoints New Board Member
Date:2/10/2011

WESTMINSTER, Colo., Feb. 10, 2011 /PRNewswire/ -- Plato BioPharma, Inc ("PBI") announced today that its Board of Directors has appointed a new director, Mr. Dan Mitchell, effective November 1, 2010.  Dan has been in the venture capital industry for over 25 years focused on early stage opportunities primarily in healthcare and biotech industries.  Dan also serves on the Boards of Directors of Kalypto Medican, GlobeImmune, and Apoplogic.

"Dan is an outstanding addition to the Plato BioPharma Board," said Craig F. Plato, CEO and founder of Plato BioPharma. "His substantial experience and financial background will serve both our shareholders and customers well as PBI continues to grow and expand its capabilities and offerings."

Dan began his venture career at the First National Bank of Chicago's Institutional Venture Capital Fund, and then co-founded Capital Health Venture Partners, a healthcare-focused venture fund in 1985.  In 1996 he co-founded Sequel Venture Partners ("Sequel"). Sequel invests in seed and early stage opportunities primarily in the Front Range of Colorado.  His prior investments include Pyxis (acq. by Cardinal Health), Genomic Solutions (acq. by Harvard Bioscience), Tetra Technologies, Quovadx, and Myogen (acq. by Gilead Sciences, Inc).

Founded in 2009, Plato BioPharma, Inc is a leading preclinical contract research organization (CRO).  The company offers expert drug discovery and development capabilities in cardiovascular, renal, pulmonary, and hepatic disease therapeutic areas.  PBI provides an integrated research platform from the in-life phase through clinical chemistry, biomarker, and histological analyses.  The company specializes in custom study design and execution engagements ranging from pharmacokinetics through disease model and proof-of-concept evaluation.  PBI is headquartered in Westminster, Colorado.

Bob Leahy 1-303-506-6960


'/>"/>
SOURCE Plato BioPharma, Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. New PLATO Sub-Analysis of CABG Patients Presented at ACC
2. Ticagrelor Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial
3. Enox Biopharma, Inc. to Present at OneMedForum Emerging Company Finance Conference.
4. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Receives New Research Grant From Hong Kong Innovation and Technology Commission
5. Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug
6. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
7. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
8. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
9. Cayenne Medical, Inc. Appoints David B. Springer President & CEO
10. SYNARC Appoints Ciaran Cooper as Vice President, Business Development
11. Onyx Pharmaceuticals Appoints Bill Ringo to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... OBP Medical , a leading ... today announced regulatory approval from Brazil,s ... Nacional de Vigilância Sanitária (ANVISA)) to market ... with integrated LED light source and smoke evacuation ... of a tissue pocket or cavity during surgical ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
(Date:10/2/2017)... announces the European launch of their new low volume, high throughput ... Cambridge, U.K on October 4th. The new ... unprecedented speed and sensitivity while using far less sample volume through ... ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... Milwaukee, WI (PRWEB) , ... October 13, 2017 , ... ... movement in medicine known as “patient engagement.” The patient is doing more than filling ... research partners. , “There is an increasing emphasis in health care and research ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical ... the primary prevention of cardiovascular diseases during the 15th Annual Women’s Health ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
Breaking Medicine News(10 mins):